Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/30/2008 | US20080268068 methods and kits for determining the presence or absence of a SPARC promoter mutation indicative of a cancer's resistance or sensitivity to a therapeutic regimen |
10/30/2008 | US20080268015 Methods and compositions for promoting localization of pharmaceutically active agents to bone |
10/30/2008 | US20080267996 Compositions for inducing an immune response against hepatitis B |
10/30/2008 | US20080267992 Sars Virus Vaccine with Adenovirus Carrier and Preparation Method Thereof, and Use of Sars Virus S Gene for Preparation of Vaccine |
10/30/2008 | US20080267990 Nucleotide sequences coding interferon inducer for use in detection of mycobacterial infection |
10/30/2008 | US20080267989 Self aggregating monomeric fusion protein for use in induction of immune response to human immunodeficiency viral infection |
10/30/2008 | US20080267987 Major histocompatibility complex polypeptide for use in targeting, detecting and purifying antigen-specific T-cells; for treatment and prevention of inflammatory, arthritic and autoimmune disease |
10/30/2008 | US20080267985 Major allergen Phl p 1 comprising reduced immunoglobulin reactivity for use in treating grass pollen allergies; immunotherapy |
10/30/2008 | US20080267974 Tumor necrosis factor specific immunoglobulin for use in diagnosis and treatment of autoimmune diseases |
10/30/2008 | US20080267971 Antibodies Directed to Angiopoietin-2 and Uses Thereof |
10/30/2008 | US20080267967 Modulation of cd200 receptors |
10/30/2008 | US20080267962 Albumin Fusion Proteins |
10/30/2008 | US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders |
10/30/2008 | US20080267953 Anti-perp recombinant antibody |
10/30/2008 | US20080267944 Expression vector comprising nucleotide sequences coding serine potease like protein for use in depleting fibrinogen from blood and diagnosing dysprothrombinemias |
10/30/2008 | US20080267943 Innate Immune Receptor Directed Biocides |
10/30/2008 | US20080267931 Compositions for Silencing the Expression of Vdac1 and Uses Thereof |
10/30/2008 | US20080267930 Biological Materials and Uses Thereof |
10/30/2008 | US20080267928 Compositions and Methods for Making Insulin-Producing Cells |
10/30/2008 | US20080267910 Nucleotide sequences coding interleukin-21/22 for use in identifying modulators for prevention and treatment of viral infection and cell proliferative disorders |
10/30/2008 | US20080267872 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization |
10/30/2008 | US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide |
10/30/2008 | US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer |
10/30/2008 | US20080265206 Enzymatic conversion of 5-norbornene-2-carbonitrile to give 5-norbornene-2-carboxylic acid with a high substrate concentration; nucleic acid encoding said polypeptide; suitable for preparation of cyclic olefin copolymers, pharmaceutical intermediates, pesticides or fragrances |
10/30/2008 | DE112006003608T5 Verfahren zur Präsentation von Zielproteinen an der Zelloberfläche unter Verwendung von Bacillus Anthracis-Exosporium A process for the presentation of target proteins on the cell surface using Bacillus anthracis exosporium |
10/30/2008 | DE102007020302A1 Verbesserte dreidimensionale biokompatible Gerüststruktur, die Nanopartikel beinhaltet Improved three-dimensional biocompatible scaffold structure, the nanoparticles includes |
10/30/2008 | CA2701601A1 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
10/30/2008 | CA2685185A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof |
10/30/2008 | CA2685182A1 Osteopontin functional epitopes, monoclonal antibody against the epitopes and uses thereof |
10/30/2008 | CA2685127A1 Glycoconjugates of rna interference agents |
10/30/2008 | CA2685056A1 Negative immunomodulation of immune responses by erp5 |
10/30/2008 | CA2684962A1 Manipulation of plant senescence using modified promoters |
10/30/2008 | CA2684834A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a |
10/30/2008 | CA2684750A1 Stable recombinant adenosine deaminase |
10/30/2008 | CA2684707A1 Mo-1, a gene associated with morbid obesity |
10/30/2008 | CA2684650A1 Expression system |
10/30/2008 | CA2684626A1 Penta-specific antibodies binding il-8, gro-alpha, gro-beta, gro-gamma and ena-78 |
10/30/2008 | CA2684575A1 Modified plant defensin |
10/30/2008 | CA2684330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins |
10/30/2008 | CA2684311A1 Microorganism detection method and apparatus |
10/30/2008 | CA2684278A1 Method for inhibiting scavenger receptor-a and increasing immune response to antigens |
10/30/2008 | CA2683836A1 Method for determination of progression risk of glaucoma |
10/30/2008 | CA2683789A1 Corn plants and seed enhanced for asparagine and protein |
10/30/2008 | CA2683691A1 Method for determination of onset risk of glaucoma |
10/30/2008 | CA2683079A1 Novel fully human anti-vap-1 monoclonal antibodies |
10/30/2008 | CA2682294A1 Plant productivity enhancement by combining chemical agents with transgenic modifications |
10/30/2008 | CA2678190A1 Novel viii factors for the treatment of type a hemophilia |
10/30/2008 | CA2677734A1 (3r)-hydroxyacyl-acp dehydratase enzymes used in the biosynthesis of mycolic acids and use of same for screening antibiotics |
10/30/2008 | CA2667637A1 Fusion proteins comprising an anti-inflammatory cytokine and an antigen for treatment of immune disorders |
10/30/2008 | CA2666968A1 Modified cyanobacteria |
10/29/2008 | EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes |
10/29/2008 | EP1985714A1 Method for detecting a target molecule employing at least two affinity probes and rolling circle replication of padlock probes |
10/29/2008 | EP1985709A1 A method for expressing proteins |
10/29/2008 | EP1985708A1 Selective targeting of viruses to neural precursor cells |
10/29/2008 | EP1985707A1 Method for the deletion of a large chromosomal region |
10/29/2008 | EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
10/29/2008 | EP1985705A2 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
10/29/2008 | EP1985704A1 Flavonoid glycosyltransferase and utilization thereof |
10/29/2008 | EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
10/29/2008 | EP1985702A2 CPG-like nucleic acids and methods of use thereof |
10/29/2008 | EP1985701A2 Genes differentially expressed in breast cancer |
10/29/2008 | EP1985700A1 Novel (s,s)-butanediol dehydrogenase, gene for the same, and use of the same |
10/29/2008 | EP1985697A1 Modified phosphatases |
10/29/2008 | EP1985695A1 Recombinant microorganism |
10/29/2008 | EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation |
10/29/2008 | EP1985631A1 Demannosylated recombinant factor VIII for the treatment of patients with hemophiila A |
10/29/2008 | EP1985630A2 T1R taste receptors and genes encoding same |
10/29/2008 | EP1985627A1 Putative chloroplast transporter as novel specific kanamycin resistance marker |
10/29/2008 | EP1985626A1 P. gingivalis antigenic composition |
10/29/2008 | EP1985625A2 Synthetic peptide constructs for the diagnosis and treatment of periodontitus associated with porphyromonas gingivalis |
10/29/2008 | EP1985306A2 TRX1 antibody and uses therefor |
10/29/2008 | EP1985303A1 Oral composition containing interferon- |
10/29/2008 | EP1985295A1 Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders |
10/29/2008 | EP1984546A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects |
10/29/2008 | EP1984524A2 Plant chimeric binding polypeptides for universal molecular recognition |
10/29/2008 | EP1984523A2 Mutant jak3 kinase in human leukemia |
10/29/2008 | EP1984513A1 Method and apparatus for heat or electromagnetic control of gene expression |
10/29/2008 | EP1984512A1 Gene expression system using alternative splicing in insects |
10/29/2008 | EP1984511A2 Selecting and stabilizing dsrna constructs |
10/29/2008 | EP1984510A2 Chimeric regulatory sequences comprising introns from dicotyledons for plant gene expression |
10/29/2008 | EP1984509A2 Production of foreign nucleic acids and polypeptides in plant systems |
10/29/2008 | EP1984508A2 Nucleic acid constructs and methods for producing altered seed oil compositions |
10/29/2008 | EP1984507A1 Method of selection and regeneration of transgenic brassica juncea on xylose |
10/29/2008 | EP1984506A2 Expression system |
10/29/2008 | EP1984505A2 Codon optimized il-15 and il-15r-alpha genes for expression in mammalian cells |
10/29/2008 | EP1984503A1 Modified coagulation factor vila with extended half-life |
10/29/2008 | EP1984502A2 Nucleic acid |
10/29/2008 | EP1984501A2 Mcp-i binding nucleic acids |
10/29/2008 | EP1984500A2 Adam10 and its uses related to infection |
10/29/2008 | EP1984499A2 Oligomeric compounds and compositions for the use in modulation of micrornas |
10/29/2008 | EP1984498A2 DOUBLE HELICAL OLIGONUCLEOTIDES INTERFERING WITH mRNA USED AS EFFECTIVE ANTICANCER AGENT |
10/29/2008 | EP1984497A2 Nucleic acid molecules and collections thereof, their application and identification |
10/29/2008 | EP1984496A1 Non-destructive procedure for the isolation of dna from plants |
10/29/2008 | EP1984495A1 Polypeptides having organophosphorus hydrolase activity and polynucleotides encoding same |
10/29/2008 | EP1984492A2 Soybean isopentenyl transferase genes and methods of use |
10/29/2008 | EP1984399A2 Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps |
10/29/2008 | EP1984397A2 Vegf variants |
10/29/2008 | EP1984393A2 Apoptosis methods, genes and proteins |
10/29/2008 | EP1984390A2 Methods for breeding glyphosate resistant plants and compositions thereof |
10/29/2008 | EP1984389A1 Zmtcrr-1 plant signal transduction gene and promoter |